 |
|
MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, Jacob George
Clin Mol Hepatol. 2023;29(Suppl):S17-S31. Published online 2022 Nov 29 DOI: https://doi.org/10.3350/cmh.2022.0367
|
|
Citations to this article as recorded by
 Liver Cancer Risk Across Metabolic Dysfunction-Associated Steatotic Liver Disease and/or Alcohol: A Nationwide Study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon
American Journal of Gastroenterology.2025; 120(2): 410. CrossRef La phospholipase A2 associée aux lipoprotéines (Lp-PLA2) : biomarqueur pertinent et cible thérapeutique ?
Dominique Bonnefont-Rousselot
Annales Pharmaceutiques Françaises.2025; 83(1): 45. CrossRef Comparing Three Ultrasound-Based Techniques for Diagnosing and Grading Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Pingping Wang, Danlei Song, JiaHao Han, Jing Zhang, Huihui Chen, Ruixia Gao, Huiming Shen, Jia Li
Academic Radiology.2025; 32(4): 1949. CrossRef The Effect of Curcumin on Glucolipid Metabolic Disorders: A Review
Lifen Mo, Siyu Wan, Tekla Zékány-Nagy, Xiaoyi Luo, Xingfen Yang
Food Reviews International.2025; 41(2): 543. CrossRef Unveiling the nexus: pyroptosis and its crucial implications in liver diseases
Zeyu Miao, Xiaorong Zhang, Yang Xu, Yan Liu, Qing Yang
Molecular and Cellular Biochemistry.2025; 480(4): 2159. CrossRef MASLD, MLA Pesarattu and Other Developments
Anil C. Anand
Journal of Clinical and Experimental Hepatology.2025; 15(1): 102465. CrossRef Elevated concurrent carotid atherosclerosis rates in patients with metabolic dysfunction-associated fatty liver disease (MAFLD) compared to non-alcoholic fatty liver disease (NAFLD): A cross-sectional observational study
Nien-Ting Chung, Chiann-Yi Hsu, Nai-Chen Shih, Jia-Jyun Wu
Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(1): 103767. CrossRef Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
Huiyan Duan, Minmin Gong, Gang Yuan, Zhi Wang
Journal of Clinical and Experimental Hepatology.2025; 15(2): 102459. CrossRef Impact of Nonalcoholic Fatty Liver Disease on Weight Loss Outcomes After One Anastomosis Gastric Bypass
Rahmatullah Athar, Masoumeh Shahsavan, Shahab Shahabi, Abdolreza Pazouki, Farah A. Husain, Mohammad Kermansaravi
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques.2025;[Epub] CrossRef Trehalose Ameliorates Nonalcoholic Fatty Liver Disease by Regulating IRE1α–TFEB Signaling Pathway
Shan Su, Xiaohong Liu, Min Zhu, Wen Liu, Jingyi Liu, Yujia Yuan, Fudong Fu, Zhiyong Rao, Jingping Liu, Yanrong Lu, Younan Chen
Journal of Agricultural and Food Chemistry.2025; 73(1): 521. CrossRef Deterioration of endothelial function as a risk factor for osteoporosis in patients with type 2 diabetes mellitus and MAFLD
Alexander E. Berezin
Acta Cardiologica.2025; 80(1): 99. CrossRef Vitamin D supplementation alleviates high fat diet-induced metabolic associated fatty liver disease by inhibiting ferroptosis pathway
Yufan Miao, Zhongyan Jiang, Hanlu Song, Yujing Zhang, Hao Chen, Wenyi Liu, Xiaonuo Wei, Longkang Li, Wenjie Li, Xing Li
European Journal of Nutrition.2025;[Epub] CrossRef Fermented rhubarb alleviates metabolic dysfunction-associated steatotic liver disease symptoms by modulating gut microbiota and activating the hepatic insulin signaling pathway
Heng Yuan, Junyu Zhou, Ting Zhang, Xuangao Wu, Chen Li, Hee-Jong Yang, Do Yeon Jeong, Sunmin Park
Food Bioscience.2025; 63: 105720. CrossRef Quercetin alleviates metabolic-associated fatty liver disease by tuning hepatic lipid metabolism, oxidative stress and inflammation
Ling Jiang, Rong Yi, Huan Chen, Shuwu Wu
Animal Biotechnology.2025;[Epub] CrossRef Valorizing Agro‐Food Waste for Nutraceutical Development: Sustainable Approaches for Managing Metabolic Dysfunction‐Associated Steatotic Liver Disease and Related Co‐Morbidities
Laura Comi, Claudia Giglione, Fationa Tolaj Klinaku, Federico Pialorsi, Valentina Tollemeto, Maria Zurlo, Antonio Seneci, Paolo Magni
Food Frontiers.2025; 6(2): 670. CrossRef Inter-organ metabolic interaction networks in non-alcoholic fatty liver disease
Yu-Hong Fan, Siyao Zhang, Ye Wang, Hongni Wang, Hongliang Li, Lan Bai
Frontiers in Endocrinology.2025;[Epub] CrossRef Altered kidney function in fatty liver disease: confronting the “MAFLD-renal syndrome”
Suleiman Al Ashi, Ali A. Rizvi, Manfredi Rizzo
Frontiers in Clinical Diabetes and Healthcare.2025;[Epub] CrossRef Correlation between hepatic steatosis severity diagnosed by ultrasound and metabolic indexes in elderly patients with MAFLD
Zhitang Liang, Renhao Huang, Lingyun Zhang
Frontiers in Medicine.2025;[Epub] CrossRef Exposure to a choline-deficient diet during pregnancy and lactation alters the liver transcriptome profile in offspring of dams with fatty liver
Joanna Mikołajczyk-Stecyna, Ewelina Zuk, Agata Chmurzynska, Malgorzata Blatkiewicz, Karol Jopek, Marcin Rucinski
Clinical Nutrition ESPEN.2025; 66: 9. CrossRef miR‐18a‐5p/PXR/SREBP2 Was Involved in MAFLD Associated With Methyl Tert‐Butyl Ether Among Petrol Station Workers
Hanyun Wang, Mingxiao Guo, Fengtao Cui, Mengdi Li, Xianan Zhang, Wei Gao, Xingqiang Fang, Li Chen, Ye Xin, Yucheng Sun, Piye Niu, Junxiang Ma
Liver International.2025;[Epub] CrossRef Metabolic dysfunction-associated fatty liver disease and risk of nephrolithiasis: a sizeable cross-sectional study
Shengqi Zheng, Tianchi Hua, Guicao Yin, Wei Zhang, Xiaoxiang Wang, Lezhong Qi, Xiayong Jing, Qibing Fan, Xiaoping Yu, Yifan Li
Frontiers in Endocrinology.2025;[Epub] CrossRef Endogenous Ethanol Production in the Human Alimentary Tract: A Literature Review
Renee Stamation
Journal of Gastroenterology and Hepatology.2025; 40(4): 783. CrossRef Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China
Liang Yu, Shiming Bao, Feng Zhu, Yanyan Xu, Fuqiang Zu, Yanwei Liu, Runbeng Jiang, Song Chen, Wei Chen
Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 345. CrossRef Research progress of cysteine transporter SLC7A11 in endocrine and metabolic diseases
Jiaqi Chen, Mengzhu Yuan, Jianping Wang
Molecular Biology Reports.2025;[Epub] CrossRef Obesity and Adipose-Derived Extracellular Vesicles: Implications for Metabolic Regulation and Disease
Michele Malaguarnera, Omar Cauli, Andrea Cabrera-Pastor
Biomolecules.2025; 15(2): 231. CrossRef Effects of GLP-1 receptor agonist therapy on resolution of steatohepatitis in non-alcoholic fatty liver disease: a systematic review and meta-analysis
Kathryn J Potter, Jackie Phinney, Tasha Kulai, Vicki Munro
Journal of the Canadian Association of Gastroenterology.2025; 8(2): 47. CrossRef IFN-γ-mediated inhibition of JAK/STAT signaling via nano-scutellarin treatment is an efficient strategy for ameliorating liver fibrosis
Ting Wang, Bangguo Liu, Juan Huang, Qixin Zhao, Hongping Shen, Tao Bi, Zengjin Liu, Yong Dai, Qin Sun
Journal of Translational Medicine.2025;[Epub] CrossRef Is type 2 diabetes a link between lung function and metabolic dysfunction–associated steatotic liver disease? Insights from population studies and Mendelian randomization
Runmin Cao, Yurun Zhang, Ling Cao, Honghe Jiang
European Journal of Gastroenterology & Hepatology.2025; 37(5): 652. CrossRef Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
Arun George Devasia, Adaikalavan Ramasamy, Chen Huei Leo
International Journal of Molecular Sciences.2025; 26(4): 1778. CrossRef Psychosocial risks in metabolic dysfunction-associated steatotic liver disease
Hanne Åström, Christine Takami Lageborn, Hannes Hagström
Expert Review of Gastroenterology & Hepatology.2025; 19(3): 273. CrossRef Racial Disparities in Mortality Rates among Patients with Hepatic Steatosis, Non-Alcoholic Fatty Liver Disease, and Non-Alcoholic Steatohepatitis: Insights from NHANES III Data
Shahrzad Bazargan-Hejazi, Cameron Hines, Myra Usmani, Chris Argueta, Deyu Pan, Arleen F. Brown
Journal of Racial and Ethnic Health Disparities.2025;[Epub] CrossRef Metabolic dysfunction-associated steatotic liver disease in adults
Daniel Q. Huang, Vincent W. S. Wong, Mary E. Rinella, Jerome Boursier, Jeffrey V. Lazarus, Hannele Yki-Järvinen, Rohit Loomba
Nature Reviews Disease Primers.2025;[Epub] CrossRef A Comprehensive Review of Metabolic Dysfunction-Associated Steatotic Liver Disease: Its Mechanistic Development Focusing on Methylglyoxal and Counterbalancing Treatment Strategies
Izabela Berdowska, Małgorzata Matusiewicz, Izabela Fecka
International Journal of Molecular Sciences.2025; 26(6): 2394. CrossRef A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman
Biomedicines.2025; 13(3): 644. CrossRef Red Meat Amino Acids for Beginners: A Narrative Review
Benjamin Barr, Danielle E. Levitt, Lauren Gollahon
Nutrients.2025; 17(6): 939. CrossRef Clinical Insights into Non-Alcoholic Fatty Liver Disease and the Therapeutic Potential of Flavonoids: An Update
Aleksandra Kozłowska
Nutrients.2025; 17(6): 956. CrossRef Sleep Disorders: Pathogenesis and Therapeutic Interventions
Cheng Liu, Zhigang He, Yanqiong Wu, Yanbo Liu, Zhixiao Li, Yifan Jia, Hongbing Xiang
MedComm.2025;[Epub] CrossRef Estimated sdLDL-C as a biomarker of hepatic steatosis severity in MASLD: a retrospective study
Shuo Jiang, Fan Zhang, Hui Yang, Xue Han, Jieru Mao, Guojun Zheng, Yan Fan
BMC Gastroenterology.2025;[Epub] CrossRef Fu brick tea supplementation ameliorates non-alcoholic fatty liver disease and associated endotoxemia via maintaining intestinal homeostasis and remodeling hepatic immune microenvironment
Gaolong Zuo, Menghua Li, Xiaoli Guo, Ling Wang, Yanyan Yao, Jian-an Huang, Zhonghua Liu, Yong Lin
Food Research International.2025; 209: 116207. CrossRef Association of occupational physical activity and sedentary behaviour with the risk of hepatocellular carcinoma: a case-control study based on the Inpatient Clinico-Occupational Database of Rosai Hospital Group
Shoko Nakazawa, Kota Fukai, Kei Sano, Yuko Furuya, Keika Hoshi, Noriko Kojimahara, Akihiro Toyota, Masaaki Korenaga, Masayuki Tatemichi
BMJ Open.2025; 15(3): e092020. CrossRef Metabolic diseases and interferon immune responses
Haiyan Zhou, Chunyan Liu, Yuerong Zhang, Hui Zheng
Interdisciplinary Medicine.2025;[Epub] CrossRef Impact of blood lead and manganese levels on metabolic dysfunction-associated steatotic liver disease prevalence: insights from NHANES (2017–2020)
Wenying Guo, Ting Weng, Yufei Song
BMC Gastroenterology.2025;[Epub] CrossRef RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, Yonghua Zhao, Youhua Xu
MedComm.2025;[Epub] CrossRef Does the hepatologist still need to rely on aminotransferases in clinical practice? A reappraisal of the role of a classic biomarker in the diagnosis and clinical management of chronic liver diseases
Patrizia Burra, Calogero Cammà, Pietro Invernizzi, Fabio Marra, Maurizio Pompili
Annals of Hepatology.2025; 30(1): 101900. CrossRef Omega-3 Fatty Acids, Furan Fatty Acids, and Hydroxy Fatty Acid Esters: Dietary Bioactive Lipids with Potential Benefits for MAFLD and Liver Health
Camil Merheb, Sabine Gerbal-Chaloin, François Casas, Mona Diab-Assaf, Martine Daujat-Chavanieu, Christine Feillet-Coudray
Nutrients.2025; 17(6): 1031. CrossRef Photon-counting CT–derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study
Tatjana Dell, Narine Mesropyan, Yannik Layer, Verena Tischler, Leonie Weinhold, Johannes Chang, Christian Jansen, Bernhard Schmidt, Markus Jürgens, Alexander Isaak, Patrick Kupczyk, Claus Christian Pieper, Carsten Meyer, Julian Luetkens, Daniel Kuetting
Radiology.2025;[Epub] CrossRef Unravelling the Role of PANoptosis in Liver Diseases: Mechanisms and Therapeutic Implications
Wanyuan Xiong, Junfeng Li, Aiping Tian, Xiaorong Mao
Liver International.2025;[Epub] CrossRef Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020
Xin Liao, Song Yu, Lin Wang, Ruyue Zhang, Ke Yu
Frontiers in Physiology.2025;[Epub] CrossRef Metrology for MRI: the field you’ve never heard of
Matt G. Hall, Matt Cashmore, Hyo-Min Cho, Bernd Ittermann, Kathryn E. Keenan, Christoph Kolbitsch, Changwoo Lee, Chengwei Li, Asante Ntata, Katie Obee, Zhang Pu, Stephen E. Russek, Karl F. Stupic, Lukas Winter, Luca Zilberti, Michael Steckner
Magnetic Resonance Materials in Physics, Biology and Medicine.2025;[Epub] CrossRef Dual inhibition of hepatic ACLY and ACSS2: A synergistic approach to combat NAFLD through lipogenesis reduction and mitochondrial enhancement
Mengdi Zhang, Jinliang Ji, Yuanyuan Lei, Fujian Qin, Yitong Tao, Ning Li, Jinlei Bian, Zhiyu Li, Maode Lai, Zhixia Qiu
Pharmacological Research.2025; 215: 107706. CrossRef Akkermansia muciniphila ameliorates olanzapine-induced metabolic dysfunction-associated steatotic liver disease via PGRMC1/SIRT1/FOXO1 signaling pathway
Hui Chen, Ting Cao, ChenQuan Lin, ShiMeng Jiao, YiFang He, ZhenYu Zhu, QiuJin Guo, RenRong Wu, HuaLin Cai, BiKui Zhang
Frontiers in Pharmacology.2025;[Epub] CrossRef MASLD or MAFLD: fatty liver by any name will pose the same challenge
Anil Chandra Anand, Dibyalochan Praharaj
Metabolism and Target Organ Damage.2025;[Epub] CrossRef Hallmarks of Cancer Cachexia: Sexual Dimorphism in Related Pathways
Setareh Satari, Inês N. R. Mota, Ana Carolina Leão Silva, Haissa Oliveira Brito, Paula A. Oliveira, Rui Miguel Gil da Costa, Rui Medeiros
International Journal of Molecular Sciences.2025; 26(9): 3952. CrossRef Sex‐Specific Impact of Metabolic Dysfunction‐Associated Fatty Liver Disease on Incident Cardiovascular Diseases and Mortality
Mahsa Abbaszadeh, Farhad Hosseinpanah, Maryam Tohidi, Sahar Karimpour Reyhan, Maryam Mahdavi, Majid Valizadeh
Endocrinology, Diabetes & Metabolism.2025;[Epub] CrossRef Relationship of serum 25(OH)D3 and PTX3 with liver fat content in patients with non-alcoholic fatty liver disease: Diagnostic value for liver fibrosis
Jian-Ji Dai, Yi Deng, Guo-Feng Wang, Kai-Qin Lin, Jian-Rong He, Xiao-Gang Hu
World Chinese Journal of Digestology.2025; 33(3): 192. CrossRef Role of regulatory T cells in inflammatory liver diseases
Linjie Yang, Song Guo Zheng
Autoimmunity Reviews.2025; 24(6): 103806. CrossRef Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies
Charilila-Loukia Ververeli, Yannis Dimitroglou, Stergios Soulaidopoulos, Evangelos Cholongitas, Constantina Aggeli, Konstantinos Tsioufis, Dimitris Tousoulis
Biomedicines.2025; 13(4): 812. CrossRef Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis
Qihua Duan, Ruixiang Hu, Yan Chen, Henry Wade, Szczepan Kaluzny, Bingrui Zhang, Rongxue Wu, Guangnan Liu, Cunchuan Wang, Edward N. Harris, Qiaozhu Su
Genes & Diseases.2025; : 101648. CrossRef Association of serum iron status with MASLD and liver fibrosis
Wenying Guo, Ting Weng, Yufei Song, Anna Di Sessa
PLOS ONE.2025; 20(4): e0319057. CrossRef Nephrological, Pulmonary, and Dermatological Complications in the Context of MAFLD/NAFLD: A Narrative Review
Vlad Pădureanu, Dalia Dop, Lucrețiu Radu, Dumitru Rădulescu, Rodica Pădureanu, Denisa Floriana Vasilica Pîrșcoveanu, Daniel Cosmin Caragea
Metabolites.2025; 15(4): 272. CrossRef Rhizoma Atractylodis Macrocephalae reduces HFD-induced NAFLD in mice through activated AMPK mediated inhibition of fatty acid synthesis
Ke Zheng, RuiShuo Zhang, Yijing Xin, Yuge Zhou, Jiacheng Lin, Weifan Huang, Fang Wang, Liu Yang, Xuehua Sun, Xiaoni Kong
Liver Research.2025;[Epub] CrossRef Increased Mechanical Index Improves Shear Wave Elastography: Pilot Study of Signal Enhancement
Scott Schoen, Michael Wang, Sunethra Dayavansha, Kim Naja, Viksit Kumar, Rimon Tadross, Kathleen Pope, Lauren Ling, David Hunt, Mary K. Peters, Ann Iafrate, Nathaniel D. Mercaldo, Kurt Sandstrom, TaeYun Kim, Mike Washburn, Theodore T. Pierce, Anthony E. S
Ultrasound in Medicine & Biology.2025;[Epub] CrossRef A Systematic Review of the Beneficial Effects of Berry Extracts on Non-Alcoholic Fatty Liver Disease in Animal Models
Alejandro García-Beltrán, Aida Lozano Melero, Rosario Martínez Martínez, Jesús María Porres Foulquie, María López Jurado Romero de la Cruz, Garyfallia Kapravelou
Nutrition Reviews.2025; 83(5): 819. CrossRef Linghe granules reduces hepatic lipid accumulation in Non-alcoholic fatty liver disease through regulating lipid metabolism and redox balance
Yuting Hu, Ni'ao Li, Rumian Zhang, Jia Wang, Dongdong Fang, Qianmei Zhou, Hua Zhang, Hong Cai, Yiyu Lu
Phytomedicine.2025; 141: 156654. CrossRef Metabolic dysfunction-associated steatotic liver disease (MASLD): Exploring systemic impacts and innovative therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, Pradeep Samal, Trilochan Satapathy, Ajazuddin
Clinics and Research in Hepatology and Gastroenterology.2025; 49(6): 102584. CrossRef Luteolin Relieves Metabolic Dysfunction-Associated Fatty Liver Disease Caused by a High-Fat Diet in Rats Through Modulating the AdipoR1/AMPK/PPARγ Signaling Pathway
Pongsakorn Taweesap, Prapassorn Potue, Juthamas Khamseekaew, Metee Iampanichakul, Banyaphon Jan-O, Poungrat Pakdeechote, Putcharawipa Maneesai
International Journal of Molecular Sciences.2025; 26(8): 3804. CrossRef Association between non-skimmed milk consumption and metabolic dysfunction-associated fatty liver disease in US adults: insights from NHANES data
Futao Wu, Fuying Zheng, Xue Li, Danzhu Wu, Honghao Li, Yingyi Zeng, Yan Tang, Side Liu, Aimin Li
BMC Gastroenterology.2025;[Epub] CrossRef Discovery of the first-in-class FABP/PPAR multiple modulator for the treatment of metabolic dysfunction-associated steatohepatitis
Ya Chen, Zibin Liao, Jianming Mao, Wenxin Wang, Yuxia Liu, Wei Dai, Zheng Wen, Sishi Liu, Yayi Chen, Yiming Ma, Xiaoying Wang, Zheng Li
European Journal of Medicinal Chemistry.2025; 291: 117635. CrossRef Astragaloside IV as a promising therapeutic agent for liver diseases: current landscape and future perspectives
Chunyan Chen, Xiaolan Bu, Liping Deng, Jiayan Xia, Xinming Wang, Li Chen, Wen Li, Jie Huang, Qixiang Chen, Cheng Wang
Frontiers in Pharmacology.2025;[Epub] CrossRef Targeting Metabolism: Innovative Therapies for MASLD Unveiled
Weixin Wang, Xin Gao, Wentong Niu, Jinping Yin, Kan He
International Journal of Molecular Sciences.2025; 26(9): 4077. CrossRef Unsupervised Test-Time Adaptation for Hepatic Steatosis Grading Using Ultrasound B-Mode Images
Pedro Vianna, Paria Mehrbod, Muawiz Chaudhary, Michael Eickenberg, Guy Wolf, Eugene Belilovsky, An Tang, Guy Cloutier
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control.2025; 72(5): 601. CrossRef Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry and Network Pharmacology Reveal the Mechanisms of Rhodiola crenulata in Improving Non-Alcoholic Fatty Liver Disease
Xin Zeng, Jianwei Wang, Qinyi Xu, Chengdan Deng, Xi Yi, Shang Wang, Ling Yao, Wei Xiang
Current Issues in Molecular Biology.2025; 47(5): 324. CrossRef Abnormalities of intracellular organelles in metabolic dysfunction-associated steatotic disease
Hidenori Kido, Eishiro Mizukoshi, Masahiro Yanagi, Li Shihui, Takuya Seike, Hidetoshi Nakagawa, Tetsumori Yamashima, Yoshitake Shiraishi, Noriyuki Ozaki, Kenichi Harada, Hikari Okada, Hisanori Goto, Kumi Kimura, Yasuhiko Yamamoto, Taro Yamashita
Journal of Gastroenterology.2025;[Epub] CrossRef Modulation of liver lipid metabolic pathways by central nervous system ER stress
Han Rae Kim, Parisa Tabiatnejad, Hovhannes Arestakesyan, Colin N. Young
American Journal of Physiology-Endocrinology and Metabolism.2025; 328(6): E833. CrossRef Unraveling the Metabolic Pathways Between Metabolic-Associated Fatty Liver Disease (MAFLD) and Sarcopenia
Marina Ribas Losasso, Maria Luiza Cesto Parussolo, Antony Oliveira Silva, Rosa Direito, Karina Quesada, Claudia Rucco Penteado Detregiachi, Marcelo Dib Bechara, Nahum Méndez-Sánchez, Ludovico Abenavoli, Adriano Cressoni Araújo, Ricardo de Alvares Goulart,
International Journal of Molecular Sciences.2025; 26(10): 4673. CrossRef Pre-MASLD: Should it be defined separately?
Hang-Kai Huang, You-Ming Li, Cheng-Fu Xu
Hepatobiliary & Pancreatic Diseases International.2024; 23(1): 1. CrossRef Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning
Tian‐Lei Zheng, Jun‐Cheng Sha, Qian Deng, Shi Geng, Shu‐Yuan Xiao, Wen‐Jun Yang, Christopher D. Byrne, Giovanni Targher, Yang‐Yang Li, Xiang‐Xue Wang, Di Wu, Ming‐Hua Zheng
Liver International.2024; 44(2): 330. CrossRef Steatotic liver disease, MASLD and risk of chronic kidney disease
Josh Bilson, Alessandro Mantovani, Christopher D. Byrne, Giovanni Targher
Diabetes & Metabolism.2024; 50(1): 101506. CrossRef Role of autophagy in betaine-promoted hepatoprotection against non-alcoholic fatty liver disease in mice
Jinuk Seo, Doyoung Kwon, Sou Hyun Kim, Mi Ran Byun, Yun-Hee Lee, Young-Suk Jung
Current Research in Food Science.2024; 8: 100663. CrossRef Taohe Chengqi decoction alleviated metabolic-associated fatty liver disease by boosting branched chain amino acids catabolism in the skeletal muscles of type 2 diabetes mellitus
Ziqiao Yuan, Hui Qiao, Ziwei Wang, Haoran Wang, Mingru Han, Wenzhou Zhang, Yang Zhou, Hozeifa Mohamed Hassan, Wen Zhao, Tingting Qin
Phytomedicine.2024; 126: 155315. CrossRef Non-Pharmacological Approach to Diet and Exercise in Metabolic-Associated Fatty Liver Disease: Bridging the Gap between Research and Clinical Practice
Hassam Ali, Muhammad Shahzil, Vishali Moond, Maria Shahzad, Abhay Thandavaram, Alina Sehar, Haniya Waseem, Taha Siddiqui, Dushyant Singh Dahiya, Pratik Patel, Hans Tillmann
Journal of Personalized Medicine.2024; 14(1): 61. CrossRef Mortality in metabolic dysfunction-associated steatotic liver disease: A nationwide population-based cohort study
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Sang Hoon Ahn, Yong-ho Lee, Seung Up Kim
Metabolism.2024; 152: 155789. CrossRef Performance Evaluation of a Novel Non-Invasive Test for the Detection of Advanced Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease
Anna Stefanska, Katarzyna Bergmann, Szymon Suwała, Aneta Mankowska-Cyl, Marek Kozinski, Roman Junik, Magdalena Krintus, Mauro Panteghini
Metabolites.2024; 14(1): 52. CrossRef Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis
Chung‐Feng Huang, Po‐Cheng Liang, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Yao Hsu, Pei‐Chien Tsai, Yu‐Ju Wei, Ming‐Lun Yeh, Ming‐Yen Hsieh, Yi‐Hung Lin, Chao‐Kuan Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu
The Kaohsiung Journal of Medical Sciences.2024; 40(4): 374. CrossRef Time-restricted eating and supervised exercise for improving hepatic steatosis and cardiometabolic health in adults with obesity: protocol for the TEMPUS randomised controlled trial
Alba Camacho-Cardenosa, Antonio Clavero-Jimeno, Juan J Martin-Olmedo, Francisco Amaro-Gahete, Rocío Cupeiro, María Trinidad González Cejudo, Patricia Virginia García Pérez, Carlos Hernández-Martínez, Raquel Sevilla-Lorente, Alejandro De-la-O, Alejandro Ló
BMJ Open.2024; 14(1): e078472. CrossRef Association of sex-specific body mass index and waist circumference trajectories with non-alcoholic fatty liver disease incidence based on growth mixture modeling
Tengrui Cao, Chao Tong, Qiang Li, Yumei Han, Aheyeerke Halengbieke, Xuetong Ni, Bo Gao, Deqiang Zheng, Xinghua Yang
Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(5): 1245. CrossRef Increased risk of colorectal adenomas with metabolic-associated fatty liver disease components
Dongsheng Ran, ChunLing Xin, Yingcai Ma, Yanyan Lu
Clinics and Research in Hepatology and Gastroenterology.2024; 48(3): 102302. CrossRef A Cross-Sectional Investigation for Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease in Tibetan College Students in Mainland
娟 周
Advances in Clinical Medicine.2024; 14(02): 2843. CrossRef The Global Epidemic of Metabolic Fatty Liver Disease
Ethan C. Z. Lee, Vickram V. Anand, Alex C. Razavi, Pamela L. Alebna, Mark D. Muthiah, Mohammad S. Siddiqui, Nicholas W. S. Chew, Anurag Mehta
Current Cardiology Reports.2024; 26(4): 199. CrossRef Liver sinusoidal endothelial cells as potential drivers of liver fibrosis (Review)
Jiaqin Gao, Bin Zuo, Yang He
Molecular Medicine Reports.2024;[Epub] CrossRef Evolving role of semaglutide in NAFLD: in combination, weekly and oral administration
Evgenia Koureta, Evangelos Cholongitas
Frontiers in Pharmacology.2024;[Epub] CrossRef Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease
Shuang Wang, Qiang Zhang, Bo Qin
Scientific Reports.2024;[Epub] CrossRef Identification of crosstalk genes relating to ECM‐receptor interaction genes in MASH and DN using bioinformatics and machine learning
Chao Chen, Yuxi He, Ying Ni, Zhanming Tang, Wensheng Zhang
Journal of Cellular and Molecular Medicine.2024;[Epub] CrossRef Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort
Liang‐Jie Tang, Dan‐Qin Sun, Sherlot Juan Song, Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong, Pei‐Wu Zhu, Sui‐Dan Chen, Morten Karsdal, Diana Julie Leeming, Pei Jiang, Cong Wang, Qiang Chen, Christopher D. Byrne, Giovanni Targher, Mohammed Eslam, Jacob Georg
Liver International.2024; 44(5): 1129. CrossRef Non-invasive diagnosis of non-alcoholic fatty liver disease: Current status and future perspective
Jia-Lan Wang, Su-Wen Jiang, Ai-Rong Hu, Ai-Wu Zhou, Ting Hu, Hong-Shan Li, Ying Fan, Ken Lin
Heliyon.2024; 10(5): e27325. CrossRef Association of multiple serum minerals and vitamins with metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017–2018
Peisen Guo, Jiahui Yu
Frontiers in Nutrition.2024;[Epub] CrossRef Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
Khamis Al Hashmi, Rosaria Vincenza Giglio, Anca Pantea Stoian, Angelo Maria Patti, Khalid Al Waili, Khalid Al Rasadi, Marcello Ciaccio, Manfredi Rizzo
Frontiers in Nutrition.2024;[Epub] CrossRef Depression and hepatobiliary diseases: a bidirectional Mendelian randomization study
Yu Kong, Zhongcai Yao, Lingli Ren, Liqin Zhou, Jinkai Zhao, Yuanyuan Qian, Dayong Lou
Frontiers in Psychiatry.2024;[Epub] CrossRef A universal plasma metabolites-derived signature predicts cardiovascular disease risk in MAFLD
Zhonglin Li, Rui Gong, Huikuan Chu, Junchao Zeng, Can Chen, Sanping Xu, Lilin Hu, Wenkang Gao, Li Zhang, Hang Yuan, Zilu Cheng, Cheng Wang, Meng Du, Qingjing Zhu, Li Zhang, Lin Rong, Xiaoqing Hu, Ling Yang
Atherosclerosis.2024; 392: 117526. CrossRef Hydroxytyrosol Linoleoyl Ether Ameliorates Metabolic-Associated Fatty Liver Disease Symptoms in Obese Zucker Rats
Rubén Tovar, Marialuisa de Ceglia, Miguel Rodríguez-Pozo, Antonio Vargas, Ana Gavito, Juan Suárez, Anna Boronat, Rafael de la Torre, Fernando Rodríguez de Fonseca, Elena Baixeras, Juan Decara
ACS Pharmacology & Translational Science.2024; 7(5): 1571. CrossRef Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study
Lin Tuo, Li-ting Yan, Yi Liu, Xing-xiang Yang
Frontiers in Endocrinology.2024;[Epub] CrossRef Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective
Yansong Fu, Zhipeng Wang, Hong Qin
Metabolites.2024; 14(4): 218. CrossRef Evidence related to a vegetarian diet and metabolic dysfunction-associated steatotic liver disease: protocol for a scoping review
Kasey Moss, Victor Gitman, M Ines Pinto Sanchez, Simon Oczkowski, David Armstrong, Saumya Jayakumar, Constantine Jason Karvellas, Nazia Selzner, Joanna Dionne
BMJ Open.2024; 14(4): e079750. CrossRef Risk of Hepatocellular Carcinoma by Steatotic Liver Disease and Its Newly Proposed Subclassification
Byeong Geun Song, Aryoung Kim, Myung Ji Goh, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Dong Hyun Sinn
Liver Cancer.2024; 13(5): 561. CrossRef Prevalence of Nonalcoholic Fatty Liver Disease [NAFLD] and Metabolic dysfunction associated Fatty Liver Disease [MAFLD] in patients with Irritable Bowel Syndrome [IBS]
Md. Musab Khalil, Sirajam Munira, Md. Mahbubul Alam, Al Mahmood Appolo, Musatafa Md. Abu Sayeed, Atikul Islam, Narwana Khaleque, Mohammad Faisal, Arifa Tasnim, Ruma Najnin, Mahmudur Rahman, Enamul Karim, Md. Golam Kibria
SN Comprehensive Clinical Medicine.2024;[Epub] CrossRef Positive association between insulin resistance and fatty liver disease in psoriasis: evidence from a cross-sectional study
Xiaoyuan Zhong, Dawei Huang, Rongfen Chen, Lingling Yao, Rui Ma, Yingyuan Yu, Yuxiong Jiang, Luyang Kong, Jiajing Lu, Ying Li, Yuling Shi
Frontiers in Immunology.2024;[Epub] CrossRef Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population
Young Lee, Eun Ju Cho, Eun Kyung Choe, Min-Sun Kwak, Jong In Yang, Seung-Won Oh, Jeong Yoon Yim, Goh Eun Chung
Scientific Reports.2024;[Epub] CrossRef Essential Oils for the Treatment and Management of Nonalcoholic Fatty Liver Disease (NAFLD)
Taehwa Kim, Mohammad Al Mijan, Jeonga Lee, Jungmi Yun, Jae Heun Chung, Soo Min Son, Ryuk Jun Kwon
Natural Product Communications.2024;[Epub] CrossRef Curcuma wenyujin rhizomes extract ameliorates lipid accumulation
Hong Wang, Lijia Chen, Ruiyu Zhang, Guanying Zhang, Jingwen Liu, Fujiang Guo
Fitoterapia.2024; 175: 105957. CrossRef The Role of PNPLA3_rs738409 Gene Variant, Lifestyle Factors, and Bioactive Compounds in Nonalcoholic Fatty Liver Disease: A Population-Based and Molecular Approach towards Healthy Nutrition
Meiling Liu, Sunmin Park
Nutrients.2024; 16(8): 1239. CrossRef Prevalence of metabolic dysfunction-associated fatty liver disease and its association with glycemic control in persons with type 2 diabetes in Africa: A systematic review and meta-analysis
Emmanuel Ekpor, Samuel Akyirem, Precious Adade Duodu, Bert B. Little
PLOS Global Public Health.2024; 4(5): e0002835. CrossRef Role of FXR in the development of NAFLD and intervention strategies of small molecules
Jiachan Long, Yuanhang Xu, Xuerong Zhang, Bingxing Wu, Caiyan Wang
Archives of Biochemistry and Biophysics.2024; 757: 110024. CrossRef Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum
Josep León-Mengíbar, Enric Sánchez, Ferrán Herrerías, Mari Cruz De La Fuente, Maite Santamaría, José Manuel Valdivielso, Marcelino Bermúdez-López, Eva Castro, Judit Pallarés, Xavier Matias-Guiu, Felip Vilardell, Assumpta Caixàs, Marta Bueno, Raquel Martí,
Frontiers in Endocrinology.2024;[Epub] CrossRef Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective
Shelley E. Keating, Yogesh Chawla, Arka De, Elena S. George
Hepatology International.2024; 18(S2): 959. CrossRef Metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatotic liver disease: general provisions
O.E. Abaturov, A.O. Nikulina
CHILD`S HEALTH.2024; 19(2): 107. CrossRef Early life exposure to vitamin D deficiency impairs molecular mechanisms that regulate liver cholesterol biosynthesis, energy metabolism, inflammation, and detoxification
Megan M. Knuth, Jing Xue, Marwa Elnagheeb, Raad Z. Gharaibeh, Sarah A. Schoenrock, Susan McRitchie, Cory Brouwer, Susan J. Sumner, Lisa Tarantino, William Valdar, R. Scott Rector, Jeremy M. Simon, Folami Ideraabdullah
Frontiers in Endocrinology.2024;[Epub] CrossRef Deconvolution analysis identified altered hepatic cell landscape in primary sclerosing cholangitis and primary biliary cholangitis
Hoang Nam Pham, Linh Pham, Keisaku Sato
Frontiers in Medicine.2024;[Epub] CrossRef Letter to the editor: Comment on “The effect of dairy products on liver fat and metabolic risk markers in males with abdominal obesity – A four-arm randomized controlled trial”
Luping Quan, Chao Ding, Yumeng Jin, Yaping Li
Clinical Nutrition.2024; 43(6): 1595. CrossRef Metabolic dysfunction associated steatotic liver disease in patients with plaque psoriasis: a case–control study and serological comparison
Zheng Lin, Yue-yi Shi, Lu-yan Yu, Chen-xi Ma, Si-yi Pan, Yuan Dou, Qiu-jun Zhou, Yi Cao
Frontiers in Medicine.2024;[Epub] CrossRef Age at menopause and risk of metabolic dysfunction-associated fatty liver disease: A 14-year cohort study
Ehn-Young Kim, Yae-Ji Lee, Yu-Jin Kwon, Ji-Won Lee
Digestive and Liver Disease.2024; 56(11): 1880. CrossRef MAFLD and glomerular hyperfiltration in subjects with normoglycemia, prediabetes and type 2 diabetes: A cross‐sectional population study
Manuela Abbate, Aneliya Parvanova, Ángel Arturo López‐González, Aina M. Yañez, Miquel Bennasar‐Veny, José Ignacio Ramírez‐Manent, Elia Reseghetti, Piero Ruggenenti
Diabetes/Metabolism Research and Reviews.2024;[Epub] CrossRef Associations of perfluoroalkyl substances with metabolic-associated fatty liver disease and non-alcoholic fatty liver disease: NHANES 2017–2018
Yuxiao Zhang, Min Zhang, Shanjiamei Jiang, Heng Hu, Xinzhi Wang, Fan Yu, Yue’e Huang, Yali Liang
Cancer Causes & Control.2024; 35(9): 1271. CrossRef Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ‐ prevalence, clinical impact, economic implications and management strategies
Pegah Golabi, Soroor Owrangi, Zobair M. Younossi
Alimentary Pharmacology & Therapeutics.2024;[Epub] CrossRef Azorella compacta Organic Extracts Exacerbate Metabolic Dysfunction-Associated Fatty Liver Disease in Mice Fed a High-Fat Diet
Jessica Zúñiga-Hernandez, Matías Quiñones San Martin, Benjamín Figueroa, Ulises Novoa, Francisco A. Monsalve, Mitchell Bacho, Aurelio San-Martin, Daniel R. González
Pharmaceuticals.2024; 17(6): 746. CrossRef Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β
Joey A. Muns, Erik Schooten, Rychon D. J. van Dasselaar, Yvet E. Noordman, Kevin Adamzek, Arthur C. Eibergen, Sebas D. Pronk, Sagel Cali, Niels J. Sijbrandi, Eugen Merkul, Sabrina Oliveira, Paul M.P. van Bergen en Henegouwen, R. Bart Takkenberg, Joanne Ve
European Journal of Nuclear Medicine and Molecular Imaging.2024; 51(12): 3545. CrossRef Comparative study of MAFLD as a predictor of metabolic disease treatment for NAFLD
Jin Imai, Shinji Takashimizu, Nana Suzuki, Kana Ohshinden, Kana Sawamoto, Yusuke Mishima, Kota Tsuruya, Yoshitaka Arase, Mitsuhiko Yamano, Noriaki Kishimoto, Chizumi Yamada, Nagamu Inoue, Kengo Moriyama, Akiyasu Baba, Hidekazu Suzuki, Tatehiro Kagawa, Yas
Scientific Reports.2024;[Epub] CrossRef Ultrasound Shear Wave Elastography Evaluation of the Liver and Implications for Perioperative Medicine
Giancarlo Suffredini, Wei Dong Gao, Jeffrey M. Dodd-o
Journal of Clinical Medicine.2024; 13(13): 3633. CrossRef Importance of the gut microbiota in the gut-liver axis in normal and liver disease
Stanislav Kotlyarov
World Journal of Hepatology.2024; 16(6): 878. CrossRef Interplay of Mediterranean-diet adherence, genetic factors, and metabolic dysfunction-associated steatotic liver disease risk in Korea
Yu-Jin Kwon, Ja-Eun Choi, Kyung-Won Hong, Ji-Won Lee
Journal of Translational Medicine.2024;[Epub] CrossRef MAFLD Pandemic: Updates in Pharmacotherapeutic Approach Development
Farah Khaznadar, Omar Khaznadar, Ana Petrovic, Marija Hefer, Fabian Gjoni, Stefan Gjoni, Justinija Steiner, Martina Smolic, Kristina Bojanic
Current Issues in Molecular Biology.2024; 46(7): 6300. CrossRef Breaking Barriers: Enhancing Statins Utilization for Cardiovascular Protection in MAFLD
Faraz Arshad
The American Journal of Medicine.2024; 137(7): e142. CrossRef Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma
Xuan Zha, Zewei Gao, Min Li, Xueli Xia, Zhenwei Mao, Shengjun Wang
Biomedicine & Pharmacotherapy.2024; 177: 116966. CrossRef Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!
Amedeo Lonardo
World Journal of Gastroenterology.2024; 30(24): 3016. CrossRef Diosgenin attenuates metabolic-associated fatty liver disease through the hepatic NLRP3 inflammasome-dependent signaling pathway
Wenfei Yu, Guoliang Yin, Suwen Chen, Xin Zhang, Decheng Meng, Linya Wang, Hongshuai Liu, Wenying Jiang, Yuqing Sun, Fengxia Zhang
International Immunopharmacology.2024; 138: 112581. CrossRef Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis
O.M. Radchenko, O.J. Komarytsia, M.O. Borovets, R.S. Ivasivka, R.R. Guta
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(3): 200. CrossRef A New Korean Nomenclature for Steatotic Liver Disease
The Korean Journal of Gastroenterology.2024; 84(1): 1. CrossRef Disinfection Byproducts of Haloacetaldehydes Disrupt Hepatic Lipid Metabolism and Induce Lipotoxicity in High-Fat Culture Conditions
Lili Yang, Zhiqiang Jiang, Lan Yang, Weiwei Zheng, Yu Chen, Fei Qu, M. James C. Crabbe, Yubin Zhang, Melvin E. Andersen, Yuxin Zheng, Weidong Qu
Environmental Science & Technology.2024; 58(28): 12356. CrossRef Association between life’s essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults
Zheng Wang, Bohan Huang, Yixuan Ding, Feng Cao, Fei Li, Prof Fei Li
Archives of Public Health.2024;[Epub] CrossRef Metformin Lowers Plasma Triacylglycerol Levels in Mice with Impaired Carnitine Biosynthesis and Fatty Liver
Bodil Bjørndal, Tra-My Thi Le, Elin Strand, Lise Madsen, Rolf K. Berge
SynBio.2024; 2(3): 240. CrossRef The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
Kiana Mohammadian, Fatemeh Fakhar, Shayan Keramat, Agata Stanek
Antioxidants.2024; 13(7): 797. CrossRef Galectin-3 and Severity of Liver Fibrosis in Metabolic
Dysfunction-Associated Fatty Liver Disease
Mohammadjavad Sotoudeheian
Protein & Peptide Letters.2024; 31(4): 290. CrossRef In vitro osteoclast differentiation enhanced by hepatocyte supernatants from high-fat diet mice
Yan Wang, Fangli Zhou, Siyi Shu, Yunhong Wu, Haoming Tian, Yujue Li, Xiang Chen
Biochemistry and Biophysics Reports.2024; 39: 101788. CrossRef Novel insights into autophagy in gastrointestinal pathologies, mechanisms in metabolic dysfunction-associated fatty liver disease and acute liver failure
Tsvetelina Velikova, Milena Gulinac
World Journal of Gastroenterology.2024; 30(27): 3273. CrossRef The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review
Liana Iordan, Laura Gaita, Romulus Timar, Vlad Avram, Adrian Sturza, Bogdan Timar
International Journal of Molecular Sciences.2024; 25(13): 7057. CrossRef Genotypic variation in CYP2E1, GCKR, and PNPLA3 among nonalcoholic steatohepatitis patients of Turkish origin
Abbas Ali Husseini
Molecular Biology Reports.2024;[Epub] CrossRef Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota–Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal
Mónica Sánchez-Tapia, Sandra Tobón-Cornejo, Lilia G. Noriega, Natalia Vázquez-Manjarrez, Diana Coutiño-Hernández, Omar Granados-Portillo, Berenice M. Román-Calleja, Astrid Ruíz-Margáin, Ricardo U. Macías-Rodríguez, Armando R. Tovar, Nimbe Torres
Nutrients.2024; 16(16): 2594. CrossRef TG: HDL, AST: ALT, A:G Ratios in Alcoholic and Non-alcoholic Fatty Liver patients
Abhinav Manish, Anuradha Bharosay, Kanchan Negi, Ritesh Srivastava
Journal of Research in Applied and Basic Medical Sciences.2024; 10(3): 279. CrossRef Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2/HO‐1 signaling pathway
Simiao Zhang, Sheng Zheng, Ya Li, Juan Yang, Xiaozhou Mao, Tao Liu, Qiuxin Zhang, ZhiPeng Fu, Xing Zhu, Long Xu
Journal of Biochemical and Molecular Toxicology.2024;[Epub] CrossRef SGLT2 inhibition leads to a restoration of hepatic and circulating metabolites involved in the folate cycle and pyrimidine biosynthesis
Ileana Mendez Espinoza, Elijah N. D. Choos, Carolyn M. Ecelbarger, Blythe D. Shepard
American Journal of Physiology-Gastrointestinal and Liver Physiology.2024; 327(2): G235. CrossRef Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation
Hiroki Yanagisawa, Hitoshi Maeda, Isamu Noguchi, Motohiko Tanaka, Naoki Wada, Taisei Nagasaki, Kazuki Kobayashi, Gai Kanazawa, Kazuaki Taguchi, Victor Tuan Giam Chuang, Hiromi Sakai, Hiroyuki Nakashima, Manabu Kinoshita, Hiroaki Kitagishi, Yasuko Iwakiri,
Redox Biology.2024; 76: 103314. CrossRef Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD
I Sabinari, O Horakova, T Cajka, V Kleinova, MR Wieckowski, M Rossmeisl
Physiological Research.2024; (Suppl 1): S295. CrossRef A New Korean Nomenclature for Steatotic Liver Disease
The Korean Journal of Medicine.2024; 99(4): 189. CrossRef Effect of Ilex hainanensis Merr. On HFD-induced nonalcoholic fatty liver disease and rebalance of gut microbiota and bile acids metabolism in mice
Jia-yi Tian, Meng Xiao, Wen-wen Zhao, Xia Wu, Jie Yang, Xiao-qing Chen
Fitoterapia.2024; 178: 106186. CrossRef The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes
Lorenzo Carciero, Gianfranco Di Giuseppe, Eleonora Di Piazza, Erfan Parand, Laura Soldovieri, Gea Ciccarelli, Michela Brunetti, Antonio Gasbarrini, Enrico C. Nista, Giovambattista Pani, Alfredo Pontecorvi, Andrea Giaccari, Teresa Mezza
Diabetes Research and Clinical Practice.2024; 216: 111837. CrossRef Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients: a 3.0 T cardiac magnetic resonance feature tracking study
Xin Tang, Rui Shi, Li Jiang, Wei-Feng Yan, Pei-Lun Han, Wen-Lei Qian, Zhi-Gang Yang, Yuan Li
Cardiovascular Diabetology.2024;[Epub] CrossRef Metabolic dysfunction‐associated steatotic liver disease and MetALD increases the risk of liver cancer and gastrointestinal cancer: A nationwide cohort study
Yewan Park, Jooyi Jung, Seungbong Han, Gi‐Ae Kim
Alimentary Pharmacology & Therapeutics.2024; 60(11-12): 1599. CrossRef Asperuloside activates hepatic NRF2 signaling to stimulate mitochondrial metabolism and restore lipid homeostasis in high fat diet-induced MAFLD
Chufeng He, Qile Zhang, Ruiwen Zhu, Gary Tse, Wing Tak Wong
European Journal of Pharmacology.2024; 983: 177003. CrossRef A New Korean Nomenclature for Steatotic Liver Disease
Gut and Liver.2024; 18(5): 924. CrossRef 3,5-Dimethyl-2,4,6-trimethoxychalcone Lessens Obesity and MAFLD in Leptin-Deficient ob/ob Mice
Stéphanie Gaigé, Anne Abysique, Rym Barbouche, Alain Tonetto, Attilio Di Maio, Maxime Robin, Anh-Tuan Lormier, Jean-Denis Troadec
International Journal of Molecular Sciences.2024; 25(18): 9838. CrossRef Novel eicosanoid signature in plasma provides diagnostic for metabolic dysfunction-associated steatotic liver disease
Oswald Quehenberger, Aaron M. Armando, Tiffany H. Cedeno, Rohit Loomba, Arun J. Sanyal, Edward A. Dennis
Journal of Lipid Research.2024; 65(10): 100647. CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease Is Associated with Increased Risk of Kidney Cancer: A Nationwide Study
Juyeon Oh, Beom Kyung Kim, Jin-Ha Yoon, Hyung Ho Lee, Heejoo Park, Jian Lee, Youngsun Park, Byungyoon Yun, Jinsoo Chung
Cancers.2024; 16(18): 3161. CrossRef Comprehensive RNA-Seq Gene Co-Expression Analysis Reveals Consistent Molecular Pathways in Hepatocellular Carcinoma across Diverse Risk Factors
Nicholas Dale D. Talubo, Po-Wei Tsai, Lemmuel L. Tayo
Biology.2024; 13(10): 765. CrossRef Tea intake and non-alcoholic fatty liver disease risk: A two-sample Mendelian randomization study
Cuncun Lu, Lixin Ke, Alexios-Fotios A. Mentis, Qiang Zhang, Ziyi Wang, Zhifei Wang
Metabolism Open.2024; 24: 100322. CrossRef Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease
Wei Guo, Ziyi Li, Gerasimos Anagnostopoulos, Wan Ting Kong, Shuangyan Zhang, Svetoslav Chakarov, Amanda Shin, Jiawen Qian, Yiwen Zhu, Wenjuan Bai, Olivier Cexus, Bin'en Nie, Jing Wang, Xiaoyu Hu, Camille Blériot, Zhaoyuan Liu, Baiyong Shen, Nicolas Ventec
Immunity.2024; 57(10): 2310. CrossRef Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma Progression
Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma
International Journal of Molecular Sciences.2024; 25(19): 10233. CrossRef Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Haixiang Zheng, Leonardo Antonio Sechi, Eliano Pio Navarese, Gavino Casu, Gianpaolo Vidili
Cardiovascular Diabetology.2024;[Epub] CrossRef A new Korean nomenclature for steatotic liver disease
Clinical and Molecular Hepatology.2024; 30(Suppl): S214. CrossRef Association of niacin intake and metabolic dysfunction-associated steatotic liver disease: findings from National Health and Nutrition Examination Survey
Jing Zhou, Jun Han
BMC Public Health.2024;[Epub] CrossRef Impact of High-Temperature Feeds on Gut Microbiota and MAFLD
Lijun Xue, Kaimin Li, Yanfei Jia, Dongxue Yao, Xuexing Guo, Shuhong Zhang
Journal of Microbiology and Biotechnology.2024; 34(9): 1789. CrossRef LncRNA Snhg3 aggravates hepatic steatosis via PPARγ signaling
Xianghong Xie, Mingyue Gao, Wei Zhao, Chunmei Li, Weihong Zhang, Jiahui Yang, Yinliang Zhang, Enhui Chen, Yanfang Guo, Zeyu Guo, Minglong Zhang, Ebenezeri Erasto Ngowi, Heping Wang, Xiaoman Wang, Yinghan Zhu, Yiting Wang, Xiaolu Li, Hong Yao, Li Yan, Fude
eLife.2024;[Epub] CrossRef Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil
Cureus.2024;[Epub] CrossRef Agile 3+ and Metabolic Dysfunction-Associated Fatty Liver Disease:
Detecting Advanced Fibrosis based on Reported Liver Stiffness
Measurement in FibroScan and Laboratory Findings
Mohammadjavad Sotoudeheian
The International Journal of Gastroenterology and Hepatology Diseases.2024;[Epub] CrossRef Higher Adherence to the Mediterranean Diet Is Associated with a Lower Risk of Steatotic, Alcohol-Related, and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Retrospective Analysis
Ji Lee, Sue Kim, Yaeji Lee, Yu-Jin Kwon, Ji-Won Lee
Nutrients.2024; 16(20): 3551. CrossRef Day napping and metabolic-associated fatty liver disease: A systematic review and meta-analysis of observational studies
Linxiao Gao, Jianping Gong, Guochao Zhong, Yajun Qin
Medicine.2024; 103(44): e40362. CrossRef Unbiased and reproducible liver MRI-PDFF estimation using a scan protocol-informed deep learning method
Juan P. Meneses, Ayyaz Qadir, Nirusha Surendran, Cristobal Arrieta, Cristian Tejos, Marcelo E. Andia, Zhaolin Chen, Sergio Uribe
European Radiology.2024; 35(5): 2843. CrossRef Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions
Duygu Ağagündüz, Özge Yeşildemir, Emine Koçyiğit, Tevfik Koçak, Buket Özen Ünaldı, Gamze Ayakdaş, Ferenc Budán
Nutrients.2024; 16(22): 3812. CrossRef Evolving epidemiology of non-alcoholic fatty liver disease in South Korea: incidence, prevalence, progression, and healthcare implications from 2010 to 2022
Jae Woo Park, Jeong-Ju Yoo, Dong Hyeon Lee, Young Chang, Hoongil Jo, Young Youn Cho, Sangheun Lee, Log Young Kim, Jae Young Jang
The Korean Journal of Internal Medicine.2024; 39(6): 931. CrossRef ASPP2 deficiency promotes the progression of metabolic dysfunction-associated steatohepatitis via ACSL4 upregulation
Jinming Wang, Quanwei Li, Yunfei Huo, Xiaoni Liu, Ying Shi, Bangxiang Xie
Scientific Reports.2024;[Epub] CrossRef Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Jaehyun Bae, Eugene Han, Hye Won Lee, Cheol-Young Park, Choon Hee Chung, Dae Ho Lee, Eun-Hee Cho, Eun-Jung Rhee, Ji Hee Yu, Ji Hyun Park, Ji-Cheol Bae, Jung Hwan Park, Kyung Mook Choi, Kyung-Soo Kim, Mi Hae Seo, Minyoung Lee, Nan-Hee Kim, So Hun Kim, Won-
Diabetes & Metabolism Journal.2024; 48(6): 1015. CrossRef Exploring the relationship between air pollution, non-alcoholic fatty liver disease, and liver function indicators: a two-sample Mendelian randomization analysis study
Qingliang Song, Jinyue Pan, Maoxing Pan, Chuiyang Zheng, Wen Fan, Jianwei Zhen, Dajin Pi, Zheng Liang, Haiyan Shen, Yuanyou Li, Qinhe Yang, Yupei Zhang
Frontiers in Endocrinology.2024;[Epub] CrossRef Western diet promotes the progression of metabolic dysfunction‐associated steatotic liver disease in association with ferroptosis in male mice
Nicole Maddie, Nefia Chacko, David Matatov, Maria Alicia Carrillo‐Sepulveda
Physiological Reports.2024;[Epub] CrossRef Coriandrum sativum L. Leaf Extract Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Modulating the AMPK Pathway in High Fat-Fed C57BL/6 Mice
Min Ji Gu, Yejin Ahn, Yu Ra Lee, Guijae Yoo, Yoonsook Kim, Inwook Choi, Sang Keun Ha, Donghwan Kim
Nutrients.2024; 16(23): 4165. CrossRef Comparative analysis of NAFLD-related health videos on TikTok: a cross-language study in the USA and China
Hongyu Wu, Jialun Peng, Shengwei Li, Xiong Ding, Tao Zhong, Qilong Zhai, Changjie Du, Jiajun Yuan, Can Cai, Jinzheng Li
BMC Public Health.2024;[Epub] CrossRef Metabolic syndrome therapy in pediatric age — between classic and modern. From diets to pipeline drugs
Otilia Elena Frăsinariu, Vasile Valeriu Lupu, Laura Mihaela Trandafir, Violeta Streanga, Elena Jechel, Iris Bararu-Bojan, Ioana Vasiliu, Magdalena Cuciureanu, Isabela Ioana Loghin, Costica Mitrofan, Alin Horatiu Nedelcu, Anton Knieling, Ancuta Lupu
Frontiers in Nutrition.2024;[Epub] CrossRef Triglycerides to apolipoprotein A1 ratio: an effective insulin resistance-associated index in identifying metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
Wei Wang, Yang Chen, Mei Tu, Hang Ju Chen
Frontiers in Endocrinology.2024;[Epub] CrossRef Does metabolic dysfunction-associated fatty liver disease increase the risk of chronic kidney disease? A meta-analysis of cohort studies
Wanghao Liu, Xiaoying Sun
BMC Nephrology.2024;[Epub] CrossRef Association between the ratio of serum uric acid to high-density lipoprotein cholesterol and liver fat content: evidence from a Chinese health examination dataset
Ao Liu, Yongbing Sun, Xin Qi, Yang Zhou, Jing Zhou, Zhonglin Li, Xiaoling Wu, Zhi Zou, Xue Lv, Hao Li, Yongli Li
Scientific Reports.2024;[Epub] CrossRef Association of serum selenium with MASLD and liver fibrosis: A cross-sectional study
Wenying Guo, Ting Weng, Yufei Song, Anna Di Sessa
PLOS ONE.2024; 19(12): e0314780. CrossRef Obesity in Adults: Position Statement of Polish Association for the Study on Obesity, Polish Association of Endocrinology, Polish Association of Cardiodiabetology, Polish Psychiatric Association, Section of Metabolic and Bariatric Surgery of the Associati
Magdalena Olszanecka-Glinianowicz, Artur Mazur, Jerzy Chudek, Beata Kos-Kudła, Leszek Markuszewski, Dominika Dudek, Piotr Major, Piotr Małczak, Wiesław Tarnowski, Paweł Jaworski, Elżbieta Tomiak
Nutrients.2023; 15(7): 1641. CrossRef Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Clinical and Molecular Hepatology.2023; 29(2): 371. CrossRef Type 2 Diabetes Mellitus, Non-Alcoholic Fatty Liver Disease, and Metabolic Repercussions: The Vicious Cycle and Its Interplay with Inflammation
Rafał Frankowski, Mateusz Kobierecki, Andrzej Wittczak, Monika Różycka-Kosmalska, Tadeusz Pietras, Kasper Sipowicz, Marcin Kosmalski
International Journal of Molecular Sciences.2023; 24(11): 9677. CrossRef MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study
Eugene Han, Ho Soo Chun, Yong‐ho Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Sang Hoon Ahn, Seung Up Kim
Journal of Gastroenterology and Hepatology.2023; 38(9): 1598. CrossRef The impact of concomitant metabolic dysfunction-associated fatty liver disease on adverse outcomes in patients with hepatitis B cirrhosis: a propensity score matching study
Xinyu Wang, Shuhang Wei, Yingnan Wei, Xueqi Wang, Feng Xiao, Yuemin Feng, Qiang Zhu
European Journal of Gastroenterology & Hepatology.2023; 35(8): 889. CrossRef Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Annals of Hepatology.2023; 28(6): 101138. CrossRef MAFLD: an optimal framework for understanding liver cancer phenotypes
Harry Crane, Cameron Gofton, Ankur Sharma, Jacob George
Journal of Gastroenterology.2023; 58(10): 947. CrossRef Liver Fibrosis Scores and Coronary Artery Disease: Novel Findings in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease
Chuan Lu, Yan Chen, Yue Zhang, Xin Zhao
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 2627. CrossRef Current insights into the interplay between gut microbiota-derived metabolites and metabolic-associated fatty liver disease
Rachmad Anres Dongoran, Fang-Cen Tu, Chin-Hung Liu
Tzu Chi Medical Journal.2023; 35(4): 290. CrossRef New Insights into the Pathogenesis of Metabolic-Associated Fatty Liver Disease (MAFLD): Gut–Liver–Heart Crosstalk
Keungmo Yang, Myeongjun Song
Nutrients.2023; 15(18): 3970. CrossRef Meeting at the Crossroad between Obesity and Hepatic Carcinogenesis: Unique Pathophysiological Pathways Raise Expectations for Innovative Therapeutic Approaches
Konstantinos Arvanitakis, Stavros P. Papadakos, Vasileios Lekakis, Theocharis Koufakis, Ioannis G. Lempesis, Eleni Papantoniou, Georgios Kalopitas, Vasiliki E. Georgakopoulou, Ioanna E. Stergiou, Stamatios Theocharis, Georgios Germanidis
International Journal of Molecular Sciences.2023; 24(19): 14704. CrossRef Potential Therapeutic Strategies in the Treatment of Metabolic-Associated Fatty Liver Disease
Aleksandra Bołdys, Łukasz Bułdak, Mateusz Maligłówka, Stanisław Surma, Bogusław Okopień
Medicina.2023; 59(10): 1789. CrossRef Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus
Alessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, Maria Masulli, Efisio Cossu, Marco Giorgio Baroni, Katia Bonomo, Flavia Agata Cimini, Gisella Cavallo, Raffaella Buzzetti, Carmen Mignogna, Frida Leonetti, Simonetta Bacci, Ro
Diabetes & Metabolism.2023; 49(6): 101477. CrossRef Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity
Gi-Ae Kim, Joon Ho Moon, Won Kim
Clinical and Molecular Hepatology.2023; 29(4): 831. CrossRef From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials
Ming-Lun Yeh, Ming-Lung Yu
Clinical and Molecular Hepatology.2023; 29(4): 969. CrossRef The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers
Amedeo Lonardo
Expert Review of Clinical Pharmacology.2023; 16(10): 891. CrossRef Vascular calcification: from the perspective of crosstalk
Shiqi Yang, Zhaolin Zeng, Qing Yuan, Qian Chen, Zuo Wang, Hui Xie, Jianghua Liu
Molecular Biomedicine.2023;[Epub] CrossRef What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications
Mariana M. Ramírez-Mejía, Nahum Méndez-Sánchez
Current Hepatology Reports.2023; 22(4): 221. CrossRef Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
Divyavani Gowda, Chandra Shekhar, Siddabasave Gowda B. Gowda, Yifan Chen, Shu-Ping Hui
Livers.2023; 3(4): 687. CrossRef Biological Role and Related Natural Products of SIRT1 in Nonalcoholic Fatty Liver
Decheng Meng, Fengxia Zhang, Wenfei Yu, Xin Zhang, Guoliang Yin, Pengpeng Liang, Yanan Feng, Suwen Chen, Hongshuai Liu
Diabetes, Metabolic Syndrome and Obesity.2023; Volume 16: 4043. CrossRef Recent Updates on the Therapeutic Prospects of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Liver Injuries
Giuseppina Palladini, Laura Giuseppina Di Pasqua, Anna Cleta Croce, Andrea Ferrigno, Mariapia Vairetti
International Journal of Molecular Sciences.2023; 24(24): 17407. CrossRef Association between carotenoid intake and metabolic dysfunction-associated fatty liver disease among US adults: A cross-sectional study
Hang Zhang, Li Li, Lei Jia, Jinchun Liu
Medicine.2023; 102(51): e36658. CrossRef
|